Suppr超能文献

肾功能不全患者静脉注射造影剂后肌酐的平均下降情况:对造影剂肾病评估的意义。

Mean creatinine decrease after administration of intravenous contrast in patients with renal dysfunction: implications for assessment of post-contrast nephrotoxicity.

作者信息

Newhouse Jeffrey H, Ahmed Firas, Ellis James

机构信息

Department of Radiology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.

Department of Radiology, Memorial Sloan Kettering Cancer Center, Montvale, NJ, USA.

出版信息

Acta Radiol. 2025 Jul;66(7):775-781. doi: 10.1177/02841851251327895. Epub 2025 Mar 20.

Abstract

BackgroundContrast nephropathy risk is traditionally assessed by the proportion of patients whose post-contrast serum creatinine (SCr) increases exceed certain thresholds. However, this method can be misleading because of random threshold selections, overlooking post-contrast creatinine decreases, and discarding continuous renal function data. The main impact of contrast on renal function can be revealed by analyzing the mean changes in SCr and evaluating their significance.PurposeTo analyze published data permitting calculation of mean SCr changes after intravenous contrast.Material and MethodsWe identified publications including patients with pre-existing renal dysfunction who received modern contrast agents, specified contrast type and dose, and means and standard deviations of SCr measurements before and after contrast.ResultsIn 14 articles, including 2057 patients, mean SCr pre-contrast was 148.6 µmol/L (1.68 mg/dL); decreasing significantly to 144.1 µmol/L (1.63 mg/dL) after contrast. Significant diminutions occurred at post-contrast intervals of 4, 7, and 10 days, and in patients who received hydration therapy. Of the patients, 6.6% met the specific thresholds for contrast nephropathy as defined by individual studies.ConclusionThe slight significant improvement in SCr after iodinated contrast suggests that some prior estimates of the risk of contrast-induced acute kidney injury (AKI) have been erroneously high and corroborates the current view that the risk of clinically important AKI after contrast is unlikely in patients with moderate renal failure. Threshold-based investigations of nephropathy may be misleading. Mean post-contrast SCr decline should be considered for clinical decisions regarding contrast administration. Future studies on the renal effects of contrast should analyze means, variation, and significance of post-contrast SCr changes.

摘要

背景

传统上,对比剂肾病风险是通过对比剂注射后血清肌酐(SCr)升高超过特定阈值的患者比例来评估的。然而,由于随机选择阈值、忽视对比剂注射后肌酐降低情况以及丢弃连续肾功能数据,这种方法可能会产生误导。通过分析SCr的平均变化并评估其显著性,可以揭示对比剂对肾功能的主要影响。

目的

分析已发表的数据,以计算静脉注射对比剂后SCr的平均变化。

材料与方法

我们确定了一些出版物,这些出版物纳入了患有既往肾功能不全且接受现代对比剂的患者,明确了对比剂类型和剂量,以及对比剂注射前后SCr测量的均值和标准差。

结果

在14篇文章中,共纳入2057例患者,对比剂注射前SCr均值为148.6 μmol/L(1.68 mg/dL);对比剂注射后显著降至144.1 μmol/L(1.63 mg/dL)。在对比剂注射后4天、7天和10天以及接受水化治疗的患者中出现了显著下降。在这些患者中,6.6%达到了个别研究定义的对比剂肾病特定阈值。

结论

碘化对比剂注射后SCr有轻微的显著改善,这表明之前对对比剂诱发急性肾损伤(AKI)风险的一些估计错误地偏高,这也证实了目前的观点,即中度肾衰竭患者对比剂注射后发生具有临床意义的AKI的风险不大。基于阈值的肾病研究可能会产生误导。在做出关于对比剂给药的临床决策时,应考虑对比剂注射后SCr的平均下降情况。未来关于对比剂肾脏效应的研究应分析对比剂注射后SCr变化的均值、变异情况和显著性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验